Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT00008151 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: cyclosporine
DRUG: fludarabine phosphate
DRUG: gemtuzumab ozogamicin
DRUG: methotrexate
DRUG: mycophenolate mofetil
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: radiation therapy

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]